Impact of disease progression date determination on progression-free survival estimates in advanced lung cancer.

MLA

Qi, Yingwei, et al. “Impact of Disease Progression Date Determination on Progression-Free Survival Estimates in Advanced Lung Cancer.” Cancer (0008543X), vol. 118, no. 21, Nov. 2012, pp. 5358–65. EBSCOhost, https://doi.org/10.1002/cncr.27528.

APA

Qi, Y., Allen Ziegler, K. L., Hillman, S. L., Redman, M. W., Schild, S. E., Gandara, D. R., Adjei, A. A., & Mandrekar, S. J. (2012). Impact of disease progression date determination on progression-free survival estimates in advanced lung cancer. Cancer (0008543X), 118(21), 5358–5365. https://doi.org/10.1002/cncr.27528

Chicago

Qi, Yingwei, Katie L. Allen Ziegler, Shauna L. Hillman, Mary W. Redman, Steven E. Schild, David R. Gandara, Alex A. Adjei, and Sumithra J. Mandrekar. 2012. “Impact of Disease Progression Date Determination on Progression-Free Survival Estimates in Advanced Lung Cancer.” Cancer (0008543X) 118 (21): 5358–65. doi:10.1002/cncr.27528.